WC
EUCRU

Wealthspring Capital’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Wealthspring Capital’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$1.31M Buy
2022
Q2 		$1.29M Sell
2022
Q1 		$1.36M Buy
2021
Q4 		$1.25M Sell
2021
Q3 		$1.25M Buy
2021
Q2 		$1.19M Hold
2021
Q1 		$1.18M Sell
2020
Q4 		$1.39M Buy